dsip cycle Peptide DSIP & Epitalon: A Functional

Weight loss trajectory was still accelerating Phase 1 (oral): 10.4-13.1% weight loss at 12 weeks depending on dosing regimen vs 1.2% placebo Phase 2 (T2D): SC amycretin showed up to 14.5% weight loss and HbA1c reductions up to 1.8% at 36 weeks

PMID: 17083573

Understanding this landscape helps set realistic expectations

Long R3 IGF-1 is modified to help increase its potency and stability while still exerting anabolic effects similar to IGF-1 Long stands for the additional 13 amino acids added to the N-terminus of the peptide molecule, while R3 describes the replacement of the 3rd amino acid in the native hormone with arginine